Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04722575 |
| Title | Combination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-risk, Resectable Melanoma (NEO-TIM) |
| Acronym | NEO-TIM |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Fondazione Melanoma Onlus |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ITA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Ospedale S.M. Annunziata - Azienda USL Toscana Centro | Bagno A Ripoli | Firenze | 50012 | Italy | Details | |
| IRCCS - Istituto Scientifico Romagnolo per la Cura e lo Studio dei Tumori (I.R.S.T) S.r.l. | Meldola | Forlì-Cesena | 47014 | Italy | Details | |
| IRCCS San Martino - IST | Genova | 16132 | Italy | Details | ||
| Fondazione I.R.C.C.S. Istituto Nazionale dei Tumori | Milano | 20133 | Italy | Details | ||
| Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione Giovanni Pascale" | Naples | 80131 | Italy | Details | ||
| Istituto Oncologico Veneto | Padova | 35128 | Italy | Details |